These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 34472901)
1. The relationship of cogniphobia to performance validity and symptom validity in neuropsychological assessment. Lee GJ; Suhr J; Henry GK; Heilbronner RL; Drane DL Neuropsychology; 2021 Oct; 35(7):762-769. PubMed ID: 34472901 [TBL] [Abstract][Full Text] [Related]
2. Performance validity and symptom validity tests: Are they measuring different constructs? Ord AS; Shura RD; Sansone AR; Martindale SL; Taber KH; Rowland JA Neuropsychology; 2021 Mar; 35(3):241-251. PubMed ID: 33829824 [TBL] [Abstract][Full Text] [Related]
3. Performance and symptom validity assessment in attention deficit/hyperactivity disorder: Base rates of invalidity, concordance, and relative impact on cognitive performance. Ovsiew GP; Cerny BM; Boer AB; Petry LG; Resch ZJ; Durkin NM; Soble JR Clin Neuropsychol; 2023 Oct; 37(7):1498-1515. PubMed ID: 36594201 [No Abstract] [Full Text] [Related]
4. Cogniphobia and neuropsychological functioning in migraine. Klepper JE; Sebrow L; Rosen NL; Seng EK Neuropsychology; 2022 Jul; 36(5):433-442. PubMed ID: 35389723 [TBL] [Abstract][Full Text] [Related]
5. Validity of informant report interpretations: Role of examinee performance and symptom invalidity. Webber TA; Sullivan-Baca E; Modiano YA; Taiwo Z; Grabyan JM Psychol Assess; 2022 Feb; 34(2):125-138. PubMed ID: 34647761 [TBL] [Abstract][Full Text] [Related]
7. Pain-related fear is associated with cognitive task avoidance: exploration of the cogniphobia construct in a recurrent headache sample. Suhr J; Spickard B Clin Neuropsychol; 2012; 26(7):1128-41. PubMed ID: 22928643 [TBL] [Abstract][Full Text] [Related]
8. Types or modes of malingering? A confirmatory factor analysis of performance and symptom validity tests. Egeland J; Andersson S; Sundseth ØØ; Schanke AK Appl Neuropsychol Adult; 2015; 22(3):215-26. PubMed ID: 25275555 [TBL] [Abstract][Full Text] [Related]
9. The importance of assessing for validity of symptom report and performance in attention deficit/hyperactivity disorder (ADHD): Introduction to the special section on noncredible presentation in ADHD. Suhr JA; Berry DTR Psychol Assess; 2017 Dec; 29(12):1427-1428. PubMed ID: 29227123 [TBL] [Abstract][Full Text] [Related]
10. German language adaptation of the Cogniphobia Scale for Headache Disorders (CS-HD) and development of a new short form (CS-HD-6). Klan T; Bräscher AK; Seng EK; Gaul C; Witthöft M Headache; 2024; 64(7):772-782. PubMed ID: 38785395 [TBL] [Abstract][Full Text] [Related]
11. The predictive utility of neuropsychological symptom validity testing as it relates to psychological presentation. Zakzanis KK; Gammada E; Jeffay E Appl Neuropsychol Adult; 2012; 19(2):98-107. PubMed ID: 23373576 [TBL] [Abstract][Full Text] [Related]
12. Performance validity in undergraduate research participants: a comparison of failure rates across tests and cutoffs. An KY; Kaploun K; Erdodi LA; Abeare CA Clin Neuropsychol; 2017 Jan; 31(1):193-206. PubMed ID: 27687709 [TBL] [Abstract][Full Text] [Related]
13. Clinical utility of the memory complaints inventory to detect invalid test performance. Armistead-Jehle P; Grills CE; Bieu RK; Kulas JF Clin Neuropsychol; 2016 May; 30(4):610-28. PubMed ID: 27117938 [TBL] [Abstract][Full Text] [Related]
14. Development of the Cogniphobia Scale for Headache Disorders (CS-HD): A pilot study. Seng EK; Klepper JE Psychol Assess; 2017 Oct; 29(10):1296-1301. PubMed ID: 28125248 [TBL] [Abstract][Full Text] [Related]
15. A Comparison of Performance Validity Measures in Predicting MMPI-2 Lie Scale Results. Richey LN; Doninger NA Clin Neuropsychol; 2020 Feb; 34(2):353-367. PubMed ID: 31340718 [No Abstract] [Full Text] [Related]